Bladder Cancer Clinical Trial

A Prospective Registry to Assess the Effectiveness and Local Tolerability of Intravesical Valrubicin in Subjects With Non-muscle Invasive Bladder Cancer (NMIBC)

Summary

The purpose of this study is to observe and describe the effectiveness and local tolerability of intravesical treatment with valrubicin for non-muscle invasive bladder cancer (NMIBC) in a cohort of subjects treated under routine practice conditions.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Males and females 18 years of age and older
Diagnosed with NMIBC
Prescribed intravesical valrubicin to treat NMIBC
Understood and signed Informed Consent to participate

Exclusion Criteria:

None

Study is for people with:

Bladder Cancer

Estimated Enrollment:

15

Study ID:

NCT01314664

Recruitment Status:

Terminated

Sponsor:

Endo Pharmaceuticals

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There are 11 Locations for this study

See Locations Near You

BCG Oncology
Phoenix Arizona, 85032, United States
Urology Research Network
Hialeah Florida, 33149, United States
Advanced Urology Association of Florida
Vero Beach Florida, 32960, United States
Kansas City Urology Care
Overland Park Kansas, 66211, United States
Delaware Valley Urology
Sewell New Jersey, 08080, United States
Delaware Valley Urology
Voorhees New Jersey, 08043, United States
Long Island Urological Associates
Bethpage New York, 11714, United States
Urologic Consultants of SE PA
Bala-Cynwyd Pennsylvania, 19004, United States
Vanderbilt University Medical Center
Nashville Tennessee, 37232, United States
Urology Associates of North Texas
Arlington Texas, 76017, United States
Urology Clinics of North Texas
Dallas Texas, 75231, United States

How clear is this clinincal trial information?

Study is for people with:

Bladder Cancer

Estimated Enrollment:

15

Study ID:

NCT01314664

Recruitment Status:

Terminated

Sponsor:


Endo Pharmaceuticals

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider